|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
ocm50426641 |
| 003 |
OCoLC |
| 005 |
20240909213021.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
020819s2002 nyua ob 101 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d YDXCP
|d OCLCQ
|d IDEBK
|d FXR
|d QT5
|d NLGGC
|d OCLCO
|d OCLCF
|d OCLCO
|d OCLCQ
|d SUR
|d UAB
|d OCLCQ
|d SAV
|d QT7
|d OCLCQ
|d OCLCO
|d INT
|d OCLCQ
|d GDC
|d CHBRC
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d SFB
|d OCLCO
|
| 019 |
|
|
|a 55046735
|a 229219902
|a 532332007
|a 702101086
|a 818972175
|a 961615130
|a 962585922
|a 984884861
|a 1007413119
|a 1053088084
|a 1135430360
|
| 020 |
|
|
|a 0306468859
|q (electronic bk.)
|
| 020 |
|
|
|a 9780306468858
|q (electronic bk.)
|
| 020 |
|
|
|a 9780792367475
|
| 020 |
|
|
|a 0792367472
|
| 035 |
|
|
|a (OCoLC)50426641
|z (OCoLC)55046735
|z (OCoLC)229219902
|z (OCoLC)532332007
|z (OCoLC)702101086
|z (OCoLC)818972175
|z (OCoLC)961615130
|z (OCoLC)962585922
|z (OCoLC)984884861
|z (OCoLC)1007413119
|z (OCoLC)1053088084
|z (OCoLC)1135430360
|
| 050 |
|
4 |
|a RS380
|b .N677 2002eb
|
| 072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
| 049 |
|
|
|a HCDD
|
| 245 |
0 |
0 |
|a Novel frontiers in the production of compounds for biomedical use,
|n Vol. 1 /
|c edited by Annie Van Broeckhoven, Fred Shapiro and Jozef Anné.
|
| 260 |
|
|
|a New York :
|b Kluwer Academic,
|c ©2002.
|
| 300 |
|
|
|a 1 online resource (v, 453 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Focus on biotechnology ;
|v v. 1
|
| 500 |
|
|
|a "Compilation of some of the outstanding presentations in the field of biomedicine made at the 9th European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999)"--Page v
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
0 |
|g pt. 1.
|t Genomics: The New Approach to the Discovery of New Compounds --
|t genomics approach: is it really the solution? /
|r Raul Goldschmidt and Karen Bush --
|t Contribution of Genomics to the Discovery of new Antibiotics /
|r David J. Holmes [and others] --
|g pt. 2.
|t Antibiotics --
|t antibiotic gallidermin -- evolution of a production process /
|r Markus Kempf, Uwe Theobald and Hans-Peter Fiedler --
|t Resistance to ß-lactams, a self-regenerating problem /
|r Jozsef Aszodi and Andre Bryskier --
|t Resistance to aminoglycoside antibiotics: Function meets structure /
|r Gerard D. Wright and Albert M. Berghuis --
|t genetics and biochemistry of resistance to glycopeptide antibiotics /
|r P.E. Reynolds --
|t ß-Lactamases, an old but ever renascent problem /
|r Andre Matagne [and others] --
|t Metabolic flux analysis in streptomyces coelicolor /
|r Fereshteh Naeimpoor and Ferda Mavituna --
|t Metabolic engineering of the lysine pathway for ß-lactam overproduction in Penicillium chrysogenum /
|r J. Casqueiro [and others] --
|t Glycosylation of antibiotics and other agents from Actinomycetes /
|r Wolfgang Piepersberg --
|t Enzymatic synthesis of amoxicillin /
|r A.C. Spiess and V. Kasche --
|g pt. 3.
|t Production of Therapeutic Antibodies --
|t New Recombinant bi- and trispecific antibody derivatives /
|r Nico Mertens [and others] --
|t Advantages of single-domain antigen-binding fragments derived from functional camel heavy-chain antibodies /
|r Muyldermans Serge [and others] --
|g pt. 4.
|t Heterologous Protein Production: New Production Strategies --
|t Furin as a tool for the endoproteolytic maturation of susceptible recombinant biopharmaceuticals /
|r M. Himmelspach [and others] -- ^
|
| 520 |
|
|
|a The present book entitled "Novel Frontiers in the Production of Compounds for Biomedical Uses" can perhaps be placed in its best perspective by the Shakespearean character in The Tempest who exclaimed" What's past is prologue". Indeed, this compilation of some of the outstanding presentations in the field of biomedicine made at th the 9 European Congress on Biotechnology (Brussels, Belgium, July 11-15, 1999) not only reflects the achievements of the recent past, but provides a privileged glimpse of the biotechnology that is emerging in the first decade of the new Millennium. It is becoming increasingly apparent that biotechnology is offering biomedicine novel approaches and solutions to develop a sorely needed new generation of biopharmaceuticals. This is all the more necessary because in recent years, new diseases have emerged with extraordinary lethality in all corners of the globe, while age-related chronic illnesses have filled the gap wherever biomedicine has made successful inroads. The rise of antibiotic resistance also poses major threats to public health. Thus, as disease patterns evolve, the rational development of new drugs is becoming urgent, not only for the clinical outcome of patients, but also in optimising the allocation of scarce health care resources through the use of cost-effective productions methods. It is in response to all these challenges that biotechnology offers new strategies that go beyond the more traditional approaches. By the mid-1990's, the number of recombinant products approved annually for therapeutic use reached double digits. With the advent of the genomics revolution.
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology.
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
0 |
|a Bioengineering.
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
7 |
|a bioengineering.
|2 aat
|
| 650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Pharmaceutical technology
|2 fast
|
| 650 |
|
7 |
|a Biotechnology
|2 fast
|
| 650 |
|
7 |
|a Bioengineering
|2 fast
|
| 650 |
|
7 |
|a Drugs
|x Design
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical biotechnology
|2 fast
|
| 655 |
|
7 |
|a proceedings (reports)
|2 aat
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
| 655 |
|
7 |
|a Actes de congrès.
|2 rvmgf
|
| 700 |
1 |
|
|a Van Broekhoven, Annie.
|
| 700 |
1 |
|
|a Shapiro, Fred.
|
| 700 |
1 |
|
|a Anné, Jozef.
|
| 711 |
2 |
|
|a European Congress on Biotechnology
|n (9th :
|d 1999 :
|c Brussels, Belgium)
|
| 776 |
0 |
8 |
|i Print version:
|t Novel frontiers in the production of compounds for biomedical use, Vol. 1.
|d New York : Kluwer Academic, ©2002
|z 0792367472
|w (DLC) 00052104
|
| 830 |
|
0 |
|a Focus on biotechnology ;
|v v. 1.
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3035433
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|